Mannkind (MNKD) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -107.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.48% |
| Dec 31, 2025 | -129.01% |
| Sep 30, 2025 | 48.09% |
| Jun 30, 2025 | -68.10% |
| Mar 31, 2025 | 33.32% |
| Dec 31, 2024 | 237.17% |
| Sep 30, 2024 | 150.34% |
| Jun 30, 2024 | 865.14% |
| Mar 31, 2024 | 378.79% |
| Dec 31, 2023 | 161.44% |
| Sep 30, 2023 | 153.04% |
| Jun 30, 2023 | 108.41% |
| Mar 31, 2023 | 71.78% |
| Dec 31, 2022 | 46.64% |
| Sep 30, 2022 | -45.83% |
| Jun 30, 2022 | -99.10% |
| Mar 31, 2022 | -243.34% |
| Dec 31, 2021 | -0.93% |
| Sep 30, 2021 | 27.82% |
| Jun 30, 2021 | -29.79% |
| Mar 31, 2021 | 13.06% |
| Dec 31, 2020 | -109.19% |
| Sep 30, 2020 | -4.00% |
| Jun 30, 2020 | 27.73% |
| Mar 31, 2020 | 47.31% |
| Dec 31, 2019 | -46.86% |
| Sep 30, 2019 | 59.25% |
| Jun 30, 2019 | 46.67% |
| Mar 31, 2019 | 49.55% |
| Dec 31, 2018 | 73.19% |
| Sep 30, 2018 | 23.55% |
| Jun 30, 2018 | 34.95% |
| Mar 31, 2018 | -36.66% |
| Dec 31, 2017 | -143.70% |
| Sep 30, 2017 | -123.83% |
| Jun 30, 2017 | -65.09% |
| Mar 31, 2017 | 2.05% |
| Dec 31, 2016 | 95.66% |
| Sep 30, 2016 | 554.67% |
| Jun 30, 2016 | 20.49% |
| Mar 31, 2016 | 7.94% |
| Dec 31, 2015 | -806.43% |
| Sep 30, 2015 | 32.05% |
| Jun 30, 2015 | 65.57% |
| Mar 31, 2015 | 47.51% |
| Dec 31, 2014 | 35.42% |
| Sep 30, 2014 | 14.51% |
| Jun 30, 2014 | -67.96% |
| Mar 31, 2014 | -13.65% |
| Dec 31, 2013 | -39.21% |
| Sep 30, 2013 | -26.14% |
| Jun 30, 2013 | 5.60% |
| Mar 31, 2013 | -7.38% |
| Dec 31, 2012 | -9.51% |
| Sep 30, 2012 | -8.28% |
| Jun 30, 2012 | -12.42% |
| Mar 31, 2012 | 10.70% |
| Dec 31, 2011 | 4.72% |
| Sep 30, 2011 | 22.96% |
| Jun 30, 2011 | -5.16% |